Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
- 1 March 2016
- journal article
- research article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 91 (3), 386-396
- https://doi.org/10.1016/j.mayocp.2015.12.017
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant MetastasisJournal of Clinical Oncology, 2013
- Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinomaGenome Medicine, 2013
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1Science, 2011
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour siteRadiotherapy and Oncology, 2011
- Transoral robotic surgery and human papillomavirus status: Oncologic resultsHead & Neck, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerThe New England Journal of Medicine, 2010
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trialInternational Journal of Radiation Oncology*Biology*Physics, 2004